stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. PSCR
    stockgist
    HomeTop MoversCompaniesConcepts
    PSCR logo

    Proto Script Pharmaceutical Corp.

    PSCR
    OTC
    Industrials
    Specialty Business Services
    Rancho Cucamonga, CA, USpsphomecare.com
    —

    At A Glance

    1

    Proto Script Pharmaceutical Corp.

    2

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Fundamentals

    How The Business Makes Money

    Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.

    Industry Specialty Business Services
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    FIFGFirst Foods Group, Inc.————
    AMCTAmerican Education Center...————
    ORGHOrgHarvest, Inc.————
    SYEVSeychelle Environmental T...————
    BRYNBryn Resources Inc.————
    OLNKOneLink Corporation————
    MHHCMHHC Enterprises Inc.————
    RBSYRoboserver Systems Corp.————
    Company Profile
    CIK0001521420
    ISINUS74373V1052
    Phone855-476-7679
    Address9830 6th Street, Rancho Cucamonga, CA, 91730, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice